Researchers discover severe side effects of approved multiple sclerosis medication
European Pharmaceutical Review | January 20, 2017
The multiple sclerosis therapy alemtuzumab can trigger severe, unpredictable side effects.This was the finding by a team led by Prof Dr Aiden Haghikia and Prof Dr Ralf Gold from the Department of Neurology of the Ruhr-Universität Bochum at St Josef’s Hospital.